JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2701
PUT
Warner Bros
WBD
$77.6B
| $4.77M | ﹤0.01% |
+355,700
| New | +$6.6M |
2022 Q2
0 quarters
|
|
|
POLY
2702
DELISTED
Plantronics, Inc.
POLY
| $4.77M | ﹤0.01% |
120,273
-552,450
| -82% | -$21.9M |
2014 Q4
30 quarters
|
|
2703
PUT
PepsiCo
PEP
$172B
| $4.73M | ﹤0.01% |
28,400
-95,400
| -77% | -$16.1M |
2018 Q2
16 quarters
|
|
2704
Harmony Biosciences
HRMY
$2.31B
| $4.73M | ﹤0.01% |
96,963
+71,620
| +283% | +$3.22M |
2020 Q3
7 quarters
|
|
2705
Powell Industries
POWL
$7.14B
| $4.73M | ﹤0.01% |
606,870
-157,251
| -21% | -$1.23M |
2015 Q4
26 quarters
|
|
2706
CALL
Las Vegas Sands
LVS
$23.5B
| $4.72M | ﹤0.01% |
+140,600
| New | +$4.86M |
2022 Q2
0 quarters
|
|
|
AMRS
2707
DELISTED
Amyris Inc.
AMRS
| $4.71M | ﹤0.01% |
2,548,772
-425,287
| -14% | -$1.25M |
2018 Q1
17 quarters
|
|
2708
iShares US Telecommunications ETF
IYZ
$1.1B
| $4.71M | ﹤0.01% |
187,555
+160,632
| +597% | +$4.34M |
2015 Q4
26 quarters
|
|
2709
AnaptysBio
ANAB
$1.45B
| $4.7M | ﹤0.01% |
231,444
-2,917
| -1% | -$64.6K |
2017 Q1
21 quarters
|
|
2710
Lazard
LAZ
$3.51B
| $4.7M | ﹤0.01% |
144,856
+2,087
| +1% | +$70.4K |
2013 Q2
36 quarters
|
|
|
PRTY
2711
DELISTED
Party City Holdco Inc.
PRTY
| $4.69M | ﹤0.01% |
3,555,454
-38,997
| -1% | -$86.3K |
2020 Q3
7 quarters
|
|
|
AIV
2712
Aimco
AIV
$280M
| $4.68M | ﹤0.01% |
731,615
-10,974,437
| -94% | -$69.2M |
2013 Q2
36 quarters
|
|
2713
Brighthouse Financial
BHF
$2.88B
| $4.67M | ﹤0.01% |
113,798
+1,278
| +1% | +$61.7K |
2017 Q3
19 quarters
|
|
2714
Teladoc Health
TDOC
$1B
| $4.67M | ﹤0.01% |
140,535
-1,706,937
| -92% | -$72.5M |
2015 Q3
27 quarters
|
|
2715
Interface
TILE
$2.02B
| $4.66M | ﹤0.01% |
371,477
-97,571
| -21% | -$1.29M |
2015 Q2
28 quarters
|
|
|
BKEP
2716
DELISTED
Blueknight Energy Partners L.P.
BKEP
| $4.65M | ﹤0.01% |
1,029,660
+132,095
| +15% | +$562K |
2021 Q1
5 quarters
|
|
2717
CALL
Agilon Health
AGL
$1.41B
| $4.65M | ﹤0.01% |
8,524
-1,476
| -15% | -$747K |
2021 Q4
2 quarters
|
|
2718
CRA International
CRAI
$1.07B
| $4.65M | ﹤0.01% |
52,032
+24,812
| +91% | +$2.08M |
2015 Q1
29 quarters
|
|
|
BNY
2719
CALL
Bank of New York Mellon
BNY
$98.7B
| $4.65M | ﹤0.01% |
111,400
+1,000
| +0.9% | +$44.5K |
2017 Q3
19 quarters
|
|
2720
PUT
Blackrock
BLK
$164B
| $4.63M | ﹤0.01% |
7,600
-7,500
| -50% | -$4.88M |
2016 Q4
22 quarters
|
|
2721
M/I Homes
MHO
$3.41B
| $4.62M | ﹤0.01% |
116,409
-18,919
| -14% | -$822K |
2013 Q2
36 quarters
|
|
|
BNY
2722
PUT
Bank of New York Mellon
BNY
$98.7B
| $4.58M | ﹤0.01% |
109,900
+4,900
| +5% | +$218K |
2017 Q3
19 quarters
|
|
2723
Collegium Pharmaceutical
COLL
$718M
| $4.58M | ﹤0.01% |
258,721
+136,736
| +112% | +$2.3M |
2017 Q3
19 quarters
|
|
2724
Kaiser Aluminum
KALU
$2.49B
| $4.58M | ﹤0.01% |
57,942
+37,954
| +190% | +$3.55M |
2013 Q2
36 quarters
|
|
2725
Vanguard Russell 3000 ETF
VTHR
$4.83B
| $4.58M | ﹤0.01% |
27,085
-1,214
| -4% | -$224K |
2021 Q3
3 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.